Search

10X Genomics Inc (Class A)

Cerrado

SectorSanidad

46.87 -0.26

Resumen

Variación precio

24h

Actual

Mínimo

41.67

Máximo

47.19

Métricas clave

By Trading Economics

Ingresos

2.8M

-13M

Ventas

-15M

151M

BPA

0.07

Margen de beneficios

-8.93

Empleados

1,178

EBITDA

19M

-937K

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

-11.57% downside

Dividendos

By Acuity

Próximas Ganancias

6 ago 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

2.5B

5.3B

Apertura anterior

47.13

Cierre anterior

46.87

Noticias sobre sentimiento de mercado

By Acuity

100%

0%

323 / 340 Clasificación en Healthcare

10X Genomics Inc (Class A) Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

20 jul 2026, 19:16 UTC

News
Correlated Moves

10X Genomics Inc. shares are lower as a report cites only 1.1% annual sales growth and ineffective growth strategies amid a declining Life Sciences Tools sector.

Comparación entre iguales

Cambio de precio

10X Genomics Inc (Class A) previsión

Precio Objetivo

By TipRanks

-11.57% descenso

Estimación a 12 Meses

Media 38.22 USD  -11.57%

Máximo 50 USD

Mínimo 20 USD

De acuerdo con 11 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para 10X Genomics Inc (Class A) Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

11 ratings

3

Comprar

8

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de 10X Genomics Inc (Class A)

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.